# Study Comparing the Clinical Efficacy and Health Outcomes of Outpatients With Mild to Moderate Community-Acquired Pneumonia (CAP) Treated With Either Telithromycin Once Daily for 7 Days, or Azithromycin Once Daily for 5 Days

> **NCT00237445** · PHASE4 · TERMINATED · sponsor: **Sanofi** · enrollment: 110 (actual)

## Conditions studied

- Pneumonia

## Interventions

- **DRUG:** telithromycin
- **DRUG:** azithromycin

## Key facts

- **NCT ID:** NCT00237445
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-11
- **Primary completion:** 2006-09
- **Final completion:** 2006-09
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2011-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00237445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00237445, "Study Comparing the Clinical Efficacy and Health Outcomes of Outpatients With Mild to Moderate Community-Acquired Pneumonia (CAP) Treated With Either Telithromycin Once Daily for 7 Days, or Azithromycin Once Daily for 5 Days". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00237445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*